Tower Research Capital »

Eagle Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $18k 3.2k 5.60
2024-03-31 $19k 3.5k 5.24
2023-09-30 $15k 945 15.77
2023-06-30 $23k 1.2k 19.44
2023-03-31 $11k 365 28.75
2022-12-31 $10k 357 28.01
2022-09-30 $211k 8.0k 26.48
2022-06-30 $52k 1.2k 44.33
2022-03-31 $129k 2.6k 49.37
2021-12-31 $194k 3.8k 50.85
2021-09-30 $65k 1.2k 56.07
2021-06-30 $33k 766 43.08
2021-03-31 $42k 1.0k 41.74
2020-12-31 $9.0k 188 47.87
2020-09-30 $32k 765 41.83
2020-06-30 $98k 2.1k 47.62
2018-12-31 $4.0k 104 38.46
2018-06-30 $27k 362 74.59
2018-03-31 $102k 2.0k 52.31
2017-12-31 $13k 246 52.85
2017-03-31 $32k 391 81.84
2016-12-31 $103k 1.3k 79.23
2016-03-31 $999 30 33.33
2015-12-31 $9.0k 100 90.00
2015-09-30 $71k 954 74.42
2015-03-31 $5.0k 126 39.68
2014-12-31 $4.0k 267 14.98
2014-09-30 $25k 2.0k 12.74
2014-03-31 $8.0k 610 13.11